REFERENCE INTERVALS AND DEVELOPMENTAL-CHANGES IN URINARY PROSTANOID EXCRETION IN HEALTHY NEWBORNS, INFANTS AND CHILDREN

被引:27
作者
LEONHARDT, A [1 ]
BUSCH, C [1 ]
SCHWEER, H [1 ]
SEYBERTH, HW [1 ]
机构
[1] UNIV HEIDELBERG, DEPT PEDIAT, W-6900 HEIDELBERG, GERMANY
关键词
CHILDREN; PROSTACYCLIN; PROSTAGLANDIN-E2; REFERENCE INTERVALS; THROMBOXANE;
D O I
10.1111/j.1651-2227.1992.tb12202.x
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Urinary excretion of prostaglandins E2, F2-alpha, E-M (7-alpha-hydroxy-5, 11-diketotetranor-prosta-1, 16-dioic acid), 6-keto F1-alpha, 2,3-dinor-6-keto-F1-alpha, thromboxane B2, 2,3-dinor-thromboxane B2 and 11-dehydrothromboxane B2 was determined by gas chromatography-mass spectrometry in 83 healthy subjects aged one day to 37 years. The excretion rates of all prostanoids increased with advancing age. After correction for 1.73 m2 body surface area, only urinary excretion rates of prostaglandins E-M and 6-keto-prostaglandin F1-alpha depended on age. Reference intervals were calculated as the 10th and 90th percentiles for prostaglandins E2 (4-27 ng/h/1.73 m2), F2-alpha (23-87 ng/h/1.73 m2), 2,3-dinor-6-keto-F1-alpha (4-19 ng/h/1.73 m2), thromboxane B2 (1-21 ng/h/1.73 m2), 2,3-dinor-thromboxane B2 (8-36 ng/h/1.73 m2) and 11-dehydro-thromboxane B2 (15-87 ng/h/1.73 m2) in all subjects, and for prostaglandins E-M and 6-keto-prostaglandin F1-alpha in subjects aged 30 days or less (110-1140 ng/h/1.73 m2 and 7-23 ng/h/1.73 m2) and older than 30 days (62-482 ng/h/1.73 m2 and 2-12 ng/h/1.73 m2). High urinary excretion of prostaglandins E-M and 6-keto-F1-alpha during the newborn period and some distinct changes in urinary excretion of prostaglandin E2 and thromboxane B2 with advancing age suggest that these prostanoids might play a specific role during child development.
引用
收藏
页码:191 / 196
页数:6
相关论文
共 39 条
  • [11] Granstrom E, 1978, Adv Prostaglandin Thromboxane Res, V5, P1
  • [12] GEOMETRIC METHOD FOR MEASURING BODY-SURFACE AREA - HEIGHT-WEIGHT FORMULA VALIDATED IN INFANTS, CHILDREN, AND ADULTS
    HAYCOCK, GB
    SCHWARTZ, GJ
    WISOTSKY, DH
    [J]. JOURNAL OF PEDIATRICS, 1978, 93 (01) : 62 - 66
  • [13] IGNATOWSKASWITA.R, 1980, PROSTAGLANDINS MED, V5, P289
  • [14] JOPPICH R, 1979, EUR J PEDIATR, V132, P253, DOI 10.1007/BF00496848
  • [15] URINARY-EXCRETION OF PROSTAGLANDINS DURING INFANCY AND CHILDHOOD - INFLUENCE OF AGE, SODIUM RESTRICTION AND POSTURE
    KNOERS, N
    FISELIER, T
    THOMAS, C
    VANDERBERG, R
    THEEUWES, A
    MONNENS, L
    [J]. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 1990, 39 (04): : 295 - 301
  • [16] LAWSON JA, 1985, ANAL BIOCHEM, V150, P463, DOI 10.1016/0003-2697(85)90536-6
  • [17] URINARY-EXCRETION OF IMMUNOREACTIVE PROSTAGLANDIN-F2-ALPHA IN HEALTHY-CHILDREN AND ADULTS
    LIJNEN, P
    VANDAMMELOMBAERTS, R
    PROESMANS, W
    VERSCHUEREN, LJ
    AMERY, A
    [J]. PROSTAGLANDINS, 1983, 26 (05): : 761 - 772
  • [18] IMPROVED SAMPLE PREPARATION FOR THE QUANTITATIVE MASS-SPECTROMETRIC DETERMINATION OF PROSTAGLANDINS IN BIOLOGICAL SAMPLES
    MULLER, H
    MRONGOVIUS, R
    SEYBERTH, HW
    [J]. JOURNAL OF CHROMATOGRAPHY, 1981, 226 (02): : 450 - 454
  • [19] URINARY PROSTAGLANDINS AND THROMBOXANE IN PATIENTS WITH CHRONIC GLOMERULONEPHRITIS
    NIWA, T
    MAEDA, K
    SHIBATA, M
    [J]. NEPHRON, 1987, 46 (03): : 281 - 287
  • [20] ESTIMATED RATE OF THROMBOXANE SECRETION INTO THE CIRCULATION OF NORMAL HUMANS
    PATRONO, C
    CIABATTONI, G
    PUGLIESE, F
    PIERUCCI, A
    BLAIR, IA
    FITZGERALD, GA
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1986, 77 (02) : 590 - 594